2._antiarrhythmic_drugs_ (1).ppt

Embed Size (px)

Citation preview

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    1/42

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    2/42

    LECTURES OUTLINE:

    Electrophysiology of the heart

    Arrhythmia: definition, mechanisms,

    types

    Drugs :class I, II, III, IV

    Guide to treat some types of

    arrhythmia

    Questions

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    3/42

    Normal conduction pathway:

    1 !A node generates

    action potential and

    deli"ers it to the atria

    and the AV node

    # $he AV node

    deli"ers the impulse

    to pur%in&e fi'ers

    ( pur%in&e fi'ers

    conduct the impulse

    to the "entricles

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    4/42

    Action potential of the heart:

    In the atria,

    pur%in&e, and

    "entricles the A)

    cur"e consists of

    * phases

    In the !A node

    and AV node, A)

    cur"e consists of

    ( phases

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    5/42

    Nonpacema%er action potential

    )hase +: fast

    upstro%e

    Due to Na

    influ-

    )hase (:

    repolari.ation

    Due to /efflu-

    )hase 0: resting

    mem'rane potential

    )hase #: plateuDue to a

    influ-

    )hase 1: partial

    repolari.ation

    Due to rapid efflu- of /

    N232 $he slope of phase + 4 conduction "elocity

    Also the pea% of phase + 4 Vma-

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    6/42

    )acema%er A)

    )hase 0: pacema%erpotential

    Na influ- and / efflu-

    and a influ- until the

    cell reaches threshold

    and then turns into

    phase +

    )hase +: upstro%e:Due to a influ-

    )hase (:repolari.ation:

    Due to / efflu-

    )acema%er cells 5automatic cells6 ha"e

    unsta'le mem'rane potential so they can

    generate A) spontaneously

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    7/42

    Effecti"e refractory period 5E7)6

    It is also called a'solute refractory period

    5A7)6 :8In this period the cell can9t 'e e-cited8$a%es place 'etween phase + and (

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    8/42

    Arrhythmia

    If the arrhythmia

    arises from the

    "entricles it is

    called "entriculararrhythmia

    If the arrhythmia

    arises from atria,

    !A node, or AVnode it is called

    supra"entricular

    arrhythmia

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    9/42

    Mechnisms of Arrhythmogenesis

    Delayed

    afterdepolari.ation

    Early

    afterdepolari.ation

    A) from !A node

    A) arises from sites

    other than !A node

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    10/42

    $his is when the

    impulse is not

    conducted from

    the atria to the

    "entricles

    1$his

    pathway is

    'loc%ed

    #$he impulse

    from this pathway

    tra"els in a

    retrograde fashion5'ac%ward6

    (!o the cells here will

    'e ree-cited 5first 'y theoriginal pathway and the

    other from the

    retrograde6

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    11/42

    ;ere is an

    accessory

    pathway in the

    heart called3undle of /ent

    8)resent only in small populations

    8

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    12/42

    Action of drugs

    In case of a'normal generation:

    Decrease of phase 0

    slope 5in pacema%ercells6

    3efore drug

    after

    phase0

    7aises the threshold

    In case of a'normal conduction:

    >conduction

    "elocity 5remem'erphase +6

    E7)

    5so the cellwon9t 'e

    ree-cited

    again6

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    13/42

    Supraventricular Arrhythmias !inus $achycardia: high sinus rate of 1++1?+'eats@min, occurs during e-ercise or other conditions

    that lead to increased !A nodal firing rate Atrial $achycardia: a series of ( or more consecuti"eatrial premature 'eats occurring at a freuency B1++@min

    )aro-ysmal Atrial $achycardia 5)A$6: tachycardia which'egins and ends in acute manner

    Atrial Clutter: sinus rate of #*+(*+ 'eats@min2 Atrial Ci'rillation: uncoordinated atrial depolari.ations2

    AV 'loc%sA conduction 'loc% within the AV node , occasionally in the

    'undle of ;is, that impairs impulse conduction from theatria to the "entricles2

    Types of Arrhythmia

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    14/42

    Ventricular Premature Beats (VPBs): caused 'y

    ectopic "entricular foci characteri.ed 'y widened Q7!2

    Ventricular Tachycardia (VT): high "entricular rate

    caused 'y a'normal "entricular automaticity or 'y

    intra"entricular reentry can 'e sustained or non

    sustained 5paro-ysmal6 characteri.ed 'y widened Q7!

    rates of 1++ to #++ 'eats@min lifethreatening2

    Ventricular Flutter "entricular depolari.ations

    B#++@min2

    Ventricular Fibrillation uncoordinated "entricular

    depolari.ations

    ventricular Arrhythmias

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    15/42

    Pharmacologic Rationale &Goals $he ultimate goal of antiarrhythmic drug

    therapy:o 7estore normal sinus rhythm and conductiono )re"ent more serious and possi'ly lethal

    arrhythmias from occurring2 Antiarrhythmic drugs are used to:

    decrease conduction "elocity change the duration of the effecti"e refractory

    period 5E7)6 suppress a'normal automaticity

    A t h th i d

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    16/42

    Antyarrhythmic drugs

    class mechanism action notes

    I Na channel 'loc%erhange the slope of

    phase +

    an a'olishtachyarrhythmia

    caused 'y reentrycircuit

    II 'loc%er >heart rate and

    conduction "elocityan indirectly alter /and a conductance

    III /channel 'loc%er

    12 action potentialduration 5A)D6 or

    effecti"e refractoryperiod 5E7)62#2 Delay

    repolari.ation2

    Inhi'it reentrytachycardia

    IV achannel 'loc%er!lowing the rate of rise

    in phase 0 of !A

    node5slide 1#6

    >conduction "elocityin !A and AV node

    8Fost antiarrhythmic drugs are proarrhythmic 5promote arrhythmia68$hey are classified according to Vaughan Williaminto four classes according to their

    effects on the cardiac action potential

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    17/42

    $hey > conduction "elocity in nonnodaltissues 5atria, "entricles, and pur%in&e

    fi'ers6$hey act on open

    Nachannels or

    inacti"ated only

    ;a"e moderate /

    channel 'loc%ade

    !o they are used

    when many Na

    channels are openedor inacti"ated 5in

    tachycardia only6'ecause in normal

    rhythm the channels

    will 'e at rest state

    so the drugs won9twor%

    Class I drugs

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    18/42

    Slowing of the rate of risein phase 0 conduction

    velocity of Vmaof the cardiac action

    potential $hey prolong muscle action

    potential "entricular 5E7)6 $hey > the slope of )hase 0

    spontaneous depolari.ation5!A node6 decreaseenhanced normalautomaticity

    $hey ma%e the

    slope more

    hori.ontal

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    19/42

    Class IA Drugs

    $hey possess intermediate rate of association and

    dissociation 5moderate effect6 with sodium channels2

    !harmaco"inetics#

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    20/42

    Class IA DrugsUses !upra"entricular and "entricular arrhythmias

    Quinidine is rarely used for supra"entriculararrhythmias Hral uinidine@procainamide are used with class III

    drugs in refractory "entricular tachycardia patients

    with implanta'le defi'rillator IV procainamide used for hemodynamically sta'le

    "entricular tachycardia IV procainamide is used for acute con"ersion of

    atrial fi'rillation including =olff)ar%inson=hite!yndrome 5=)=!6

    defi'rillator

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    21/42

    Class IA Drugs Toxicity

    !ystemic lupus erythromatosus 5!

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    22/42

    Notes:

    $orsades de pointes: twisting of the point 2 $ype of

    tachycardia that gi"es special characteristics on EG

    At large dosesof uinidine cinchonism occurs:'lurred "ision, tinnitus, headache,

    psychosis and gastrointestinal upset

    Digo-in is administered 'efore uinidine to pre"ent the con"ersion of atrial fi'rillation or

    flutter into parado-ical "entricular tachycardia

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    23/42

    Class IB Drugs

    $hey shorten )hase (repolari.ation

    > the duration of the cardiacaction potential

    $hey suppress arrhythmiascaused 'y a'normalautomaticity

    $hey show rapid association $dissociation5wea% effect6 with

    Na,channels with apprecia'ledegree of usedependence

    No effect on conduction "elocity

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    24/42

    Agents of Class IB

    %idocaine

    Used IV because o e!tensive"stpass metabolism

    #idocaine is the dru$ o choice

    in emer$ency treatment o

    ventricular arrhythmias

    %as &'S eects: drosiness

    numbness convulstion andnysta$mus

    Meiletine

    These are the oral analo$s o lidocaine

    *e!iletine is used or chronic

    treatment o ventricular arrhythmias

    associated ith previous myocardial

    inarction

    &ses$hey are used in the treatment of "entricular arrhythmias arising during myocardial

    ischemia or due to digo-in to-icity

    $hey ha"e little effect on atrial or AV &unction arrhythmias 5'ecause they don9t act onconduction "elocity6

    Ad"erse effects:

    1neurological effects #negati"e inotropic acti"ity

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    25/42

    Class IC Drugs

    $hey mar"edly slow !hase 0fastdepolari.ation $hey mar%edly slow conduction in

    the myocardial tissue $hey possess slow rate of

    association and dissociation'strong effect( with sodiumchannels

    $hey only ha"e minor eects onthe duration o action potential

    and reractoriness $hey reduce automaticity 'y

    increasing the threshold potentialrather than decreasing the slope of)hase 0 spontaneous

    depolari.ation2

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    26/42

    Uses:

    7efractory "entricular arrhythmias2 Clecainide is a particularly potent suppressant of premature

    "entricular contractions 5'eats6

    Toicity and Cautions for Class IC )rugs# $hey are severe proarrhythmogenic drugscausing:

    12 se"ere worsening of a pree-isting arrhythmia

    #2 de no"o occurrence of lifethreatening "entricular tachycardia In patients with freuent premature "entricular contraction 5)V6

    following FI, flecainide increased mortality compared to placebo.

    *otice# Class +C drugs are particularly of low safety and have

    shown even increase mortality when used chronically after MI

    &ompare beteen class IA IB and I& dru$s as

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    27/42

    &ompare beteen class IA IB and I& dru$s as

    re$ards eect on 'a+ channel , -.P

    Sodium channel bloc/ade:

    I& 0 IA 0 IB Increasin$ the -.P:

    IA0I&0IB (loered) 3ecause of/ 'loc%ade

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    28/42

    DRUGS

    (-are!ergic "loc#ers$

    Uses $reatment of increased

    sympathetic acti"ityinducedarrhythmias such as stressand e-erciseinduced

    arrhythmias Atrial flutter and fi'rillation2 AV nodal tachycardia2 7educe mortality in post

    myocardial infarction patients )rotection against suddencardiac death

    Fechanism of action Negati"e inotropic

    and chronotropicaction2

    )rolong AVconduction 5delay6

    Diminish phase 0depolari.ation

    suppressingautomaticity5ofectopic focus6

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    29/42

    Class II ANTIARRHYTHMICDRUGS

    Propranolol (nonselective): was pro"ed toreduce the incidence of sudden arrhythmaticdeath after myocardial infarction

    *etoprolol reduce the ris% of 'ronchospasm ,smolol# Esmolol is a "ery shortacting 1adrenergic

    'loc%er that is used 'y intra"enous route in acutearrhythmias occurring during surgery oremergencies

    selecti"e

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    30/42

    DRUGS

    %& "loc#ers

    )rolongation of phase (repolari.ation without alteringphase + upstro%e or the restingmem'rane potential

    $hey prolong 'oth the durationof the action potential and E7)

    $heir mechanism of action isstill not clear 'ut it is thoughtthat they 'loc% potassiumchannels

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    31/42

    Uses: Ventricular arrhythmias, especially "entricular

    fi'rillation or tachycardia !upra"entricular tachycardia

    Amiodarone usage is limited due to its widerange of side effects

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    32/42

    Sotalol 'Sotacor( !otalol also prolongs the duration of action potential and

    refractoriness in all cardiac tissues 5'y action of /, 'loc%ade6 !otalol suppresses )hase 0 spontaneous depolari.ation and

    possi'ly producing se"ere sinus 'radycardia 5'y 'loc%adeaction6

    $he adrenergic 'loc%ade com'ined with prolonged actionpotential duration may 'e of special efficacy in pre"ention ofsustained "entricular tachycardia

    It may induce the polymorphic torsades de pointes "entriculartachycardia 5'ecause it increases E7)6

    I'utilidesed in atrial fi'rillation or flutterIV administrationFay lead to torsade de pointesHnly drug in class three that possess pure / 'loc%ade

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    33/42

    Amiodarone (Cordarone) Amiodarone is a drug of multiple actions and is still not well understood

    It is e-tensi"ely ta%en up 'y tissues, especially fatty tissues 5e-tensi"edistri'ution6

    t1@#4 J+ days )otent )0*+ inhi'itor Amiodarone antiarrhythmic effect is comple- comprising class I II III

    and IV actions8 Dominant effect: )rolongation of action potential duration and refractoriness8 It slows cardiac conduction, wor%s as a#channel 'loc%er, and as a wea%

    adrenergic 'loc%er

    Toicity Fost common include GI intolerance, tremors, ata-ia, di..iness, and hyper

    or hypothyrodism orneal microdeposits may 'e accompanied with distur'ed night "ision Hthers: li"er to-icity, photosensiti"ity, gray facial discoloration, neuropathy,

    muscle wea%ness, and weight loss $he most dangerous side effect ispulmonary fi-rosiswhich occurs in

    #*K of the patients

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    34/42

    DRUGS

    (Calciu C)a!!el Bloc#ers$

    alcium channel 'loc%ers decreaseinward a#,currents resulting in adecrease of phase 0 spontaneousdepolari.ation 5!A node6

    $hey slow conductance in a#,currentdependent tissues li%e AVnode2

    E-amples: "erapamil diltia.em3ecause they act on the heart only

    and not on 'lood "essels2 Dihydropyridine family are not used

    'ecause they only act on 'lood "essels

    Mec)a!is o*

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    35/42

    Mec)a!is o*actio!

    $hey 'ind only to depolari.ed 5open6 channels pre"ention of repolari.ation

    $hey prolong E7) of AV node >conduction of impulses from the atria to the"entricles

    !o they act only in cases of arrhythmia 'ecause many a#

    channels are depolari.ed while in normal rhythm many of them

    are at rest

    Fore effecti"e in treatment of atrial than "entricular arrhythmias2$reatment of supra"entricular tachycardia pre"enting theoccurrence of "entricular arrhythmias$reatment of atrial flutter and fi'rillation

    Uses

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    36/42

    contraindication ontraindicated in patients with pree-isting

    depressed heart function 'ecause of their negati"einotropic acti"ity

    Ad"erse effects

    ause 'radycardia, and asystole especially whengi"en in com'ination with adrenergic 'loc%ers

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    37/42

    Miscella!eous A!tiarr)yt)icDrugs

    Adenosine

    o Adenosine activatesA1purinergic receptorsdecreasing the !A nodal firing and automaticity,reducing conduction "elocity, prolonging effecti"erefractory period, and depressing AV nodalconducti"ity

    o It is the drug of choice in the treatment ofparo-ysmal supra"entricular tachycardia

    o It is used only 'y slow intra"enous 'oluso It only has a lowprofile to-icity 5lead to

    'ronchospasm6 'eing e-tremly short acting for 1*seconds only

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    38/42

    class -&1 2T &onductionvelocity .eractoryperiod

    IA >

    I3 + no >

    I > no

    II + >In !AN andAVN

    in !AN andAVN

    III No

    IV + > in !AN andAVN

    in !AN andAVN

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    39/42

    1st: 7educe throm'us formation 'y using anticoagulant warfarin

    #nd

    : )re"ent the arrhythmia from con"erting to "entricular arrhythmia:Cirst choice: class II drugs:8After FI or surgery8A"oid in case of heart failure

    !econd choice: class IV

    $hird choice: digo-in8Hnly in heart failure of left "entricular dysfunction

    (rd: on"ersion of the arrhythmia into normal sinus rhythm:

    lass III:

    IV i'utilide, IV@oral amiodarone, or oral sotalol

    lass IA:

    Hral uinidine digo-in 5or any drug from the #ndstep6

    lass I:

    Hral propaphenone or IV@oral flecainide

    se direct current in case

    of unsta'le hemodynamic

    patient

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    40/42

    Cirst choice: class II8IV followed 'y oral

    8Early after FI

    !econd choice: amiodarone

    A"oid using

    class I after

    FI

    mortality

    Cirst choice:

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    41/42

    :LMOPR5IA, I, class III6 torsades de pointes2

    lasses II and IV 'radycardia 5don9t com'ine the two6

    In atrial flutter use 51st>impulses from atria to "entricular to pre"ent

    "entricular tachycardia612lass II

    #2lass IV

    (2Digo-in25 6

    #ndcon"ert atrial flutter to normal sinus rhythm use:

    12I'utilide

    #2!otalol

    (2IA or I25 6

    If you use uinidine com'ine it with digo-in or 'loc%er 5'ecause of its anti

    muscarinic effect6

    A"oid I in myocardial infarction 'ecause it mortality

  • 7/26/2019 2._antiarrhythmic_drugs_ (1).ppt

    42/42

    1 In "entricular tachycardia and sta'le hemodynamic which drug to 'e usedS

    A propranolol3 procainamide

    uinidine

    D "erapamil

    # Fr2Green de"loped an arrhythmia and was treated2 A month later, he has arthralgia,

    fe"er, pleural inflammation2 =hat was the treatment of arrhythmiaS

    A esmolol

    3 class III

    procainamide

    D propafenone

    ( inchonism occurs with digo-in

    A pulmonary fi'rosis diltia.em

    3 'radycardia amiodarone

    5C6